Breaking News Instant updates and real-time market news.

SU

Suncor

$27.76

-0.17 (-0.61%)

, IMO

Imperial Oil

$32.17

-0.43 (-1.32%)

16:35
10/07/16
10/07
16:35
10/07/16
16:35

Suncor weighing sale of retail gas station business, Reuters reports

Suncor Energy (SU) is considering selling its Petro-Canada retail gasoline station business in an effort to monetize the asset, Reuters reports, citing two sources familiar with the situation. The news comes following the decision by Imperial Oil (IMO), which is majority-owned by Exxon Mobil (XOM), to agree to sell 497 Esso gas stations for $2.11B, the report notes. Suncor might be able to fetch a similar valuation, though the price would also depend on the terms of the deals the company has with retailers, the report says. Reference Link

SU

Suncor

$27.76

-0.17 (-0.61%)

IMO

Imperial Oil

$32.17

-0.43 (-1.32%)

XOM

Exxon Mobil

$86.74

-0.3 (-0.34%)

  • 16

    Oct

SU Suncor
$27.76

-0.17 (-0.61%)

06/22/16
TDSI
06/22/16
UPGRADE
TDSI
Buy
Suncor upgraded to Buy from Speculative Buy at TD Securities
06/23/16
SBSH
06/23/16
UPGRADE
SBSH
Buy
Suncor upgraded to Buy from Neutral at Citi
Citigroup upgraded Suncor to Buy saying a recovery in oil above $50-$60/bbl should drive significant free cash flow generation, and returns for shareholders.
08/19/16
08/19/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Aratana Therapeutics (PETX) assumed with a Buy at Jefferies. 2. Arbutus Biopharma (ABUS) initiated with an Outperform at William Blair. 3. Acceleron (XLRN) initiated with a Buy at BTIG. 4. Agios Pharmaceuticals (AGIO) initiated with a Neutral at BTIG. 5. Suncor (SU) reinstated with a Buy at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/19/16
BOFA
08/19/16
INITIATION
Target $33
BOFA
Buy
Suncor reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Frank McGann reinstated coverage on Suncor with a Buy rating and $33 price target.
IMO Imperial Oil
$32.17

-0.43 (-1.32%)

08/25/16
JPMS
08/25/16
INITIATION
JPMS
Neutral
Imperial Oil initiated with a Neutral at JPMorgan
JPMorgan analyst Phil Gresh initiated Imperial Oil with a Neutral rating and C$43 price target.
08/19/16
BOFA
08/19/16
INITIATION
Target $32
BOFA
Underperform
Imperial Oil initiated with an Underperform at BofA/Merrill
BofA/Merrill analyst Frank McGann reinstated coverage on Cenovus Energy with an Underperform rating and $32 price target.
05/05/16
TDSI
05/05/16
UPGRADE
TDSI
Buy
Imperial Oil upgraded to Buy from Hold at TD Securities
TD Securities upgraded Imperial Oil to Buy citing year-to-date share underperformance.
09/22/16
RAJA
09/22/16
UPGRADE
RAJA
Outperform
Imperial Oil upgraded to Outperform from Market Perform at Raymond James
Raymond James analyst Chris Cox upgraded Imperial Oil to Outperform with a C$50 price target citing the company's "robust" free cash flow outlook and "strong" operational momentum.
XOM Exxon Mobil
$86.74

-0.3 (-0.34%)

08/16/16
BOFA
08/16/16
NO CHANGE
BOFA
Energy Sector raised to Overweight from Market Weight at BofA/Merrill
BofA/Merrill's commodity strategist team upgraded the Energy Sector to Overweight saying most of the selloff in oil prices is behind us and oil production continues to fall as investment and rig counts have dropped. The team said the oil market deficit will last through 2020 unless oil prices are sustained above $80/bbl and expects earnings expectations to continue to move higher.
06/02/16
06/02/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Exxon Mobil (XOM) downgraded to Neutral from Buy at BofA/Merrill with analysts led by Doug Leggate saying Exxon's strong relative performance discount's long-term oil at around $73/bbl and said shares appear to be fairly valued. 2. Intuitive Surgical (ISRG) downgraded to Neutral from Buy at Goldman with analyst David Roman saying the risk/reward looks balanced at current share levels. Roman lowered his price target for the stock to $674 from $690. 3. DeVry (DV) downgraded to Neutral from Outperform at Credit Suisse with analyst Trace Urdan saying he no longer feels confident in his investment thesis following the resignation of CFO Tim Wiggins. 4. Franklin Resources (BEN) downgraded to Sell from Neutral at UBS with analyst Brennan Hawken arguing the company is the most exposed to the Department of Labor's fiduciary rule of the names he covers given its reliance on the broker sold channel coupled with weak investment performance. He cut his price target for the shares to $28 from $39. 5. Progressive (PGR) downgraded to Sell from Neutral at Citi with analyst James Naklicki saying consensus margin and earnings expectations are too optimistic. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/05/16
FBCO
07/05/16
NO CHANGE
FBCO
Outperform
Fluor scope on 'imminent' project could be multiple billions, says Credit Suisse
Credit Suisse Jamie Cook noted that the Tengizchevron joint venture, which is 50% owned by Chevron (CVX), 25% by ExxonMobil (XOM), 20% owned by KazMunayGas, and 5% owned by Lukoil, has announced plans to move forward with the TCO project, adding that Fluor (FLR) has been doing extensive work on TCO with its JV partner WorleyParsons and that most investors believed the likelihood of this project moving forward was "minimal." Cook, who believes Fluor's scope on this project could be "north of a couple billion" and that the company could book this award in Q2 or Q3 of this year, has an Outperform rating on Fluor shares.
08/15/16
BERN
08/15/16
DOWNGRADE
BERN
Market Perform
InterOil downgraded following acquisition at Bernstein
As noted earlier, Bernstein downgraded InterOil (IOC) to Market Perform from Outperform. Analyst Neil Beveridge downgraded the stock after the company agreed to be acquired by ExxonMobil (XOM). Target $52.

TODAY'S FREE FLY STORIES

NCSM

NCS Multistage

21:17
04/27/17
04/27
21:17
04/27/17
21:17
Syndicate
NCS Multistage 9.5M share IPO priced at $17.00 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

CLDR

Cloudera

21:14
04/27/17
04/27
21:14
04/27/17
21:14
Syndicate
Cloudera 15M share IPO priced at $15.00, above the range »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 28

    Apr

21:05
04/27/17
04/27
21:05
04/27/17
21:05
General news
Japan's data dump revealed tepid inflation and mixed growth figures »

Japan's data dump…

AOS

A.O. Smith

$54.42

1.45 (2.74%)

20:16
04/27/17
04/27
20:16
04/27/17
20:16
Downgrade
A.O. Smith rating change at KeyBanc »

A.O. Smith downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

FB

Facebook

$147.70

1.14 (0.78%)

20:11
04/27/17
04/27
20:11
04/27/17
20:11
Hot Stocks
Facebook improves 'Rights Manager' content protection system »

Facebook introduced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 08

    May

  • 16

    May

AAWW

Atlas Air

$59.80

0.4 (0.67%)

20:11
04/27/17
04/27
20:11
04/27/17
20:11
Downgrade
Atlas Air rating change at Stifel »

Atlas Air downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 24

    May

UTHR

United Therapeutics

$120.50

0.51 (0.43%)

20:00
04/27/17
04/27
20:00
04/27/17
20:00
Hot Stocks
United Therapeutics announces $250M repurchase program »

United Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

CYTR

CytRx

$0.68

-0.121 (-15.02%)

19:56
04/27/17
04/27
19:56
04/27/17
19:56
Hot Stocks
CytRx: Former 'SPA' for aldoxorubicin no longer applicable »

CytRx disclosed in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

EEX

Emerald Expositions Events

19:52
04/27/17
04/27
19:52
04/27/17
19:52
Syndicate
Emerald Expositions Events 15.5M share IPO priced at $17.00 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

GOOG

Alphabet

$874.25

2.52 (0.29%)

, GOOGL

Alphabet Class A

$891.44

2.3 (0.26%)

19:31
04/27/17
04/27
19:31
04/27/17
19:31
Hot Stocks
Google introduces development kit for Google Assistant »

Google announced in a…

GOOG

Alphabet

$874.25

2.52 (0.29%)

GOOGL

Alphabet Class A

$891.44

2.3 (0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

  • 16

    May

  • 22

    May

SRPT

Sarepta

$34.72

-0.14 (-0.40%)

19:26
04/27/17
04/27
19:26
04/27/17
19:26
Hot Stocks
Sarepta: 'Productive' payer talks, ramping of patient starts continuing in Q2 »

"The number of exon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

SRPT

Sarepta

$34.72

-0.14 (-0.40%)

19:22
04/27/17
04/27
19:22
04/27/17
19:22
Hot Stocks
Sarepta: Guidance includes only U.S. sales »

"Our guidance only…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

SRPT

Sarepta

$34.72

-0.14 (-0.40%)

19:20
04/27/17
04/27
19:20
04/27/17
19:20
Hot Stocks
Sarepta: Exondys post-market commitment data likely unavailable for couple years »

"The final protocols…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

SRPT

Sarepta

$34.72

-0.14 (-0.40%)

19:18
04/27/17
04/27
19:18
04/27/17
19:18
Hot Stocks
Sarepta confirms CEO Ed Kaye to resign from role at end of current term »

Sarepta confirmed in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

BSAC

Santander Chile

$23.59

-0.36 (-1.50%)

19:02
04/27/17
04/27
19:02
04/27/17
19:02
Earnings
Santander Chile reports Q1 EPS 46c, consensus 42c »

Reports Q1 ROAE up 140…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

BA

Boeing

$183.22

1.51 (0.83%)

, BDRBF

Bombardier

$1.63

-0.0278 (-1.67%)

19:01
04/27/17
04/27
19:01
04/27/17
19:01
Hot Stocks
Canada gov't objects to Boeing allegations over Bombardier pricing in U.S. »

The Government of Canada…

BA

Boeing

$183.22

1.51 (0.83%)

BDRBF

Bombardier

$1.63

-0.0278 (-1.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

BA

Boeing

$183.22

1.51 (0.83%)

, BDRBF

Bombardier

$1.63

-0.0278 (-1.67%)

18:56
04/27/17
04/27
18:56
04/27/17
18:56
Periodicals
Boeing requests U.S. take action on Bombardier C series prices in U.S., FT says »

Boeing (BA) is aiming to…

BA

Boeing

$183.22

1.51 (0.83%)

BDRBF

Bombardier

$1.63

-0.0278 (-1.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

SWN

Southwestern Energy

$7.67

-0.16 (-2.04%)

18:48
04/27/17
04/27
18:48
04/27/17
18:48
Earnings
Southwestern Energy reports Q1 adjusted EPS 18c, consensus 18c »

Reports Q1 revenue $846M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

CRMD

CorMedix

$1.04

-0.07 (-6.31%)

18:43
04/27/17
04/27
18:43
04/27/17
18:43
Syndicate
CorMedix files to sell common stock warrants, no amount given »

H.C. Wainwright & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 28

    Apr

FET

Forum Energy

$18.10

-1.05 (-5.48%)

18:39
04/27/17
04/27
18:39
04/27/17
18:39
Earnings
Breaking Earnings news story on Forum Energy »

Forum Energy sees Q2 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

WDC

Western Digital

$85.71

1.1 (1.30%)

18:38
04/27/17
04/27
18:38
04/27/17
18:38
Hot Stocks
Western Digital: NAND supply-demand likely favorable through 'at least' 1H18 »

"Industry-wide…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

FET

Forum Energy

$18.10

-1.05 (-5.48%)

18:38
04/27/17
04/27
18:38
04/27/17
18:38
Earnings
Forum Energy reports Q1 adjusted EPS (14c), consensus (16c) »

Reports Q1 revenue $171M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

SJR

Shaw Communications

$21.30

0.07 (0.33%)

18:36
04/27/17
04/27
18:36
04/27/17
18:36
Hot Stocks
Shaw Communications restores internet and phone services after brief outage »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTRX

Matrix Service

$16.88

-0.575 (-3.30%)

18:33
04/27/17
04/27
18:33
04/27/17
18:33
Earnings
Breaking Earnings news story on Matrix Service »

Matrix Service sees FY17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIMO

Gigamon

$36.00

-0.6 (-1.64%)

18:33
04/27/17
04/27
18:33
04/27/17
18:33
Earnings
Gigamon sees Q2 adjusted EPS 2c-7c, consensus 19c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 12

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.